{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T20:42:52Z","timestamp":1768682572803,"version":"3.49.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T00:00:00Z","timestamp":1716681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T00:00:00Z","timestamp":1716681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004375","name":"Tel Aviv University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To assess the prevalence, microbial profile, and clinical risk factors of maternal bacteremia associated with intrapartum fever (IPF).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective cohort study, in a single tertiary university-affiliated medical center between 2012 and 2018. Demographic and labor characteristics of women, who delivered at term (37+0\/7\u201341+6\/7) and developed bacteremia following IPF were compared to a control group of women with IPF but without bacteremia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During the study period there were 86,590 deliveries in our center. Of them, 2074 women (2.4%) were diagnosed with IPF, of them, for 2052 women (98.93%) the blood maternal cultures were available. In 26 patients (1.25%) maternal bacteremia was diagnosed. A lower rate of epidural anesthesia (84.6% vs 95.9%, <jats:italic>p<\/jats:italic>\u2009=\u20090.02) and a higher rate of antibiotics prophylaxis treatment prior to the onset of fever (30.8%.vs 12.1%, <jats:italic>p<\/jats:italic>\u2009=\u20090.006) were observed in patients who developed maternal bacteremia in comparison to those who have not. Maternal hyperpyrexia developed after initiation of antibiotics or without epidural anesthesia remained significantly associated with maternal bacteremia after applying a multivariate analysis, (Odds Ratio 3.14 95% CI 1.27\u20137.14, <jats:italic>p<\/jats:italic>\u2009=\u20090.009; 4.76 95% CI 1.35\u201312.5, <jats:italic>p<\/jats:italic>\u2009=\u20090.006; respectively).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Maternal fever developing after initiation of antibiotics or without epidural is associated with maternal bacteremia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00404-024-07564-5","type":"journal-article","created":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T18:01:20Z","timestamp":1716746480000},"page":"195-202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intrapartum fever complicated with maternal bacteremia: prevalence, bacteriology, and risk factors"],"prefix":"10.1007","volume":"310","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4236-4836","authenticated-orcid":false,"given":"Emmanuel","family":"Attali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Kern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Warshaviak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Reicher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariel","family":"Many","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yariv","family":"Yogev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuval","family":"Fouks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,26]]},"reference":[{"issue":"6","key":"7564_CR1","doi-asserted-by":"publisher","first-page":"596.e1","DOI":"10.1016\/j.ajog.2017.02.022","volume":"216","author":"CV Towers","year":"2017","unstructured":"Towers CV, Yates A, Zite N, Smith C, Chernicky L, Howard B (2017) Incidence of fever in labor and risk of neonatal sepsis. Am J Obstet Gynecol 216(6):596.e1-596.e5. https:\/\/doi.org\/10.1016\/j.ajog.2017.02.022","journal-title":"Am J Obstet Gynecol"},{"issue":"RR10","key":"7564_CR2","first-page":"1","volume":"59","author":"JR Verani","year":"2010","unstructured":"Verani JR, McGee L, Schrag SJ (2010) Morbidity and mortality weekly report prevention of perinatal group B streptococcal disease. Revised guidleines from CDC, 2010. Morb Mortal Wkly Rep 59(RR10):1\u201336","journal-title":"Morb Mortal Wkly Rep"},{"key":"7564_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/JCM12093329","author":"O Zamstein","year":"2023","unstructured":"Zamstein O, Wainstock T, Sheiner E (2023) Intrapartum maternal fever and long-term infectious morbidity of the offspring. J Clin Med. https:\/\/doi.org\/10.3390\/JCM12093329","journal-title":"J Clin Med"},{"key":"7564_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0222958","author":"DY Arce","year":"2019","unstructured":"Arce DY, Bellavia A, Cantonwine DE et al (2019) Average and time-specific maternal prenatal inflammatory biomarkers and the risk of labor epidural associated fever. PLoS ONE. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0222958","journal-title":"PLoS ONE"},{"issue":"3","key":"7564_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/15513810600908461","volume":"25","author":"A Maayan-Metzger","year":"2006","unstructured":"Maayan-Metzger A, Mazkereth R, Shani A, Kuint J (2006) Risk factors for maternal intrapartum fever and short-term neonatal outcome. Fetal Pediatr Pathol 25(3):169\u2013177. https:\/\/doi.org\/10.1080\/15513810600908461","journal-title":"Fetal Pediatr Pathol"},{"issue":"9","key":"7564_CR6","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1055\/S-0028-1085624\/ID\/29","volume":"25","author":"A Bensal","year":"2008","unstructured":"Bensal A, Weintraub AY, Levy A, Holcberg G, Sheiner E (2008) The significance of peripartum fever in women undergoing vaginal deliveries. Am J Perinatol 25(9):567\u2013572. https:\/\/doi.org\/10.1055\/S-0028-1085624\/ID\/29","journal-title":"Am J Perinatol"},{"issue":"4","key":"7564_CR7","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1097\/AOG.0000000000002266","volume":"130","author":"SR Easter","year":"2017","unstructured":"Easter SR, Molina RL, Venkatesh KK, Kaimal A, Tuomala R, Riley LE (2017) Clinical risk factors associated with peripartum maternal bacteremia. Obstet Gynecol 130(4):710\u2013717. https:\/\/doi.org\/10.1097\/AOG.0000000000002266","journal-title":"Obstet Gynecol"},{"issue":"2","key":"7564_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/AOG.0000000000003055","volume":"133","author":"GL Wilkie","year":"2019","unstructured":"Wilkie GL, Prabhu M, Ona S et al (2019) Microbiology and antibiotic resistance in peripartum bacteremia. Obstet Gynecol 133(2):269\u2013275. https:\/\/doi.org\/10.1097\/AOG.0000000000003055","journal-title":"Obstet Gynecol"},{"issue":"1","key":"7564_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/2045-4015-2-6","volume":"2","author":"GM Ginsberg","year":"2013","unstructured":"Ginsberg GM, Eidelman AI, Shinwell E, Anis E, Peyser R, Lotan Y (2013) Should Israel screen all mothers-to-be to prevent early-onset of neonatal group B streptococcal disease? a cost-utility analysis. Isr J Health Policy Res 2(1):6. https:\/\/doi.org\/10.1186\/2045-4015-2-6","journal-title":"Isr J Health Policy Res"},{"key":"7564_CR10","unstructured":"M100Ed31 Performance standards for antimicrobial susceptibility testing, 31st edition. https:\/\/clsi.org\/standards\/products\/microbiology\/documents\/m100\/. Accessed 21 Apr 2021"},{"issue":"9","key":"7564_CR11","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1055\/S-0037-1600128","volume":"34","author":"Y Fouks","year":"2017","unstructured":"Fouks Y, Many A, Orbach R et al (2017) Is there a role for placental cultures in cases of clinical chorioamnionitis complicating preterm premature rupture of membranes? Am J Perinatol 34(9):867\u2013873. https:\/\/doi.org\/10.1055\/S-0037-1600128","journal-title":"Am J Perinatol"},{"issue":"6","key":"7564_CR12","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1213\/ANE.0000000000003866","volume":"129","author":"R Gat","year":"2019","unstructured":"Gat R, Hadar E, Orbach-Zinger S, Shochat T, Kushnir S, Einav S (2019) Distribution of extreme vital signs and complete blood count values of healthy parturients. Anesth Analg 129(6):1595\u20131606. https:\/\/doi.org\/10.1213\/ANE.0000000000003866","journal-title":"Anesth Analg"},{"issue":"2","key":"7564_CR13","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.1097\/AOG.0000000000002236","volume":"130","author":"Committee Opinion No","year":"2017","unstructured":"Committee Opinion No (2017) 712: Intrapartum management of intraamniotic infection. Obstet Gynecol 130(2):e95\u2013e101. https:\/\/doi.org\/10.1097\/AOG.0000000000002236","journal-title":"Obstet Gynecol"},{"key":"7564_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/J.AJOG.2021.07.020","author":"TC Bank","year":"2021","unstructured":"Bank TC, Nuss E, Subedi K, Hoffman MK, Sciscione A (2021) Outcomes associated with antibiotic administration for isolated maternal fever in labor. Am J Obstet Gynecol. https:\/\/doi.org\/10.1016\/J.AJOG.2021.07.020","journal-title":"Am J Obstet Gynecol"},{"key":"7564_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejogrb.2020.12.052","volume":"258","author":"E Attali","year":"2021","unstructured":"Attali E, Kern G, Reicher L et al (2021) Early preterm meconium stained amniotic fluid is an independent risk factor for peripartum maternal bacteremia. Eur J Obstet Gynecol Reprod Biol 258:75\u201379. https:\/\/doi.org\/10.1016\/j.ejogrb.2020.12.052","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"7564_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1055\/S-2000-9283","volume":"17","author":"R Gonen","year":"2000","unstructured":"Gonen R, Korobochka R, Degani S, Gaitini L (2000) Association between epidural analgesia and intrapartum fever. Am J Perinatol 17(3):127\u2013130. https:\/\/doi.org\/10.1055\/S-2000-9283","journal-title":"Am J Perinatol"},{"issue":"3","key":"7564_CR17","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000504805","volume":"117","author":"S Jansen","year":"2020","unstructured":"Jansen S, Lopriore E, Naaktgeboren C et al (2020) Epidural-related fever and maternal and neonatal morbidity: a systematic review and meta-analysis. Neonatology 117(3):259\u2013270. https:\/\/doi.org\/10.1159\/000504805","journal-title":"Neonatology"},{"key":"7564_CR18","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2020.1779694","author":"C Ward","year":"2020","unstructured":"Ward C, Caughey AB (2020) Does the presence of epidural analgesia reduce the risk of neonatal sepsis in the setting of an intrapartum fever? J Matern Fetal Neonatal Med. https:\/\/doi.org\/10.1080\/14767058.2020.1779694","journal-title":"J Matern Fetal Neonatal Med"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07564-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-024-07564-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07564-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T12:12:50Z","timestamp":1718194370000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-024-07564-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,26]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["7564"],"URL":"https:\/\/doi.org\/10.1007\/s00404-024-07564-5","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,26]]},"assertion":[{"value":"2 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The trial was conducted in accordance with the Declaration of Helsinki (2000) for human studies (IRB number TLV-0284-08).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study was approved by the Institutional Review Board (IRB) which waived the requirement of informed consent. (Approval 0284-08).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB board rule"}}]}}